Diabetic nephropathy (DN) is the leading cause of renal failure in Western societies. Development of new therapies is hindered by the lack of a clear understanding of disease pathogenesis. Recent studies revealed that loss of kidney podocytes is an early cardinal feature that contributes to the development and progression of DN;however, the underlying mechanism of podocyte loss remains unclear. Podocytes are specialized, terminally differentiated cells that maintain the kidney's filtration barrier. Recent studies have shown that hyperglycemia and advanced glycation end products (AGEs) increase oxidant stress leading to podocyte apoptosis. AGE-induced podocyte apoptosis is mediated by the activation of the FOXO4 transcription factor. The goal of this study is to study the role of FOXO4 and a protein deacetylase (SIRT1) that acts upstream of FOXO4 pathway in podocyte apoptosis of diabetes. Deacetylation of FOXO3 by SIRT1 enhances the expression of antioxidant enzymes and DNA damage repair genes, but decreases the expression of apoptosis genes. SIRT1 is repressed in diabetic rats and patients with DN. We hypothesize that SIRT1 repression in the diabetic milieu increases FOXO4 acetylation. Thus, the expression of FOXO4 target genes shifts from oxidant detoxification and DNA damage repair to apoptosis;and podocytes are apoptosis prone and oxidatively stressed in diabetes.
The first aim of the project is to determine the role of the SIRT1/FOXO4 pathway in oxidant generation and apoptosis.
The second aim i s to confirm the in vitro findings in animal models of diabetes. The effects of hyperglycemia and AGEs on FOXO4 acetylation will be determined. The role of SIRT1 in hyperglycemia- and AGE-induced FOXO4 acetylation will be assessed by gene knockdown and over-expression of SIRT1. The effects of AGE and high glucose on oxidant stress will be quantified by flow-cytometric measurements of DCF-DA fluorescence and dimerization of homovanillic acid. Apoptosis will be assessed by flow cytometry, TUNEL staining, and caspase assays. Gene expression will be quantified by real-time PCR and Western blot. The role of SIRT1 repression by AGEs will be determined by benfotiamine treatment of db/db mice to reduce AGEs formation. The role of SIRT1 in apoptosis will be assessed in podocyte-specific SIRT1 knockout mice with streptozotocin-induced diabetes. The long-term objectives of the study are to elucidate the pathogenesis of podocyte loss in human and identify novel targets for treatment of DN.
Diabetic kidney disease is the number one cause of renal failure requiring dialysis or renal transplantation in Western society. No treatment from our current therapeutic armamentarium can reverse or completely forestall the progression of the diabetic nephropathy. This study could give new insight into the pathogenesis of diabetic nephropathy and provide targets for novel therapy.
| Fan, Ying; Xiao, Wenzhen; Li, Zhengzhe et al. (2015) RTN1 mediates progression of kidney disease by inducing ER stress. Nat Commun 6:7841 |
| Li, Xuezhu; Chuang, Peter Y; D'Agati, Vivette D et al. (2015) Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys. J Am Soc Nephrol 26:2361-77 |
| Liu, Ruijie; Zhong, Yifei; Li, Xuezhu et al. (2014) Role of transcription factor acetylation in diabetic kidney disease. Diabetes 63:2440-53 |
| Chuang, Peter Y; Xu, Jin; Dai, Yan et al. (2014) In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells. Am J Pathol 184:1940-56 |
| Li, Xuezhu; Dai, Yan; Chuang, Peter Y et al. (2014) Induction of retinol dehydrogenase 9 expression in podocytes attenuates kidney injury. J Am Soc Nephrol 25:1933-41 |
| Menon, Madhav C; Chuang, Peter Y; He, John Cijiang (2013) Role of podocyte injury in IgA nephropathy. Contrib Nephrol 181:41-51 |
| Zhong, Yifei; Chen, Edward Y; Liu, Ruijie et al. (2013) Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase. J Am Soc Nephrol 24:801-11 |
| Chuang, Peter Y; Menon, Madhav C; He, John C (2013) Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) 91:549-59 |
| Menon, Madhav C; Chuang, Peter Y; He, John C (2013) Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease. Am J Physiol Renal Physiol 305:F1542-3 |
| Menon, Madhav C; Chuang, Peter Y; He, John Cijiang (2013) Shenqi particle: a novel therapy for idiopathic membranous nephropathy. Am J Kidney Dis 62:1027-9 |
Showing the most recent 10 out of 25 publications
